These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16134727)

  • 1. Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis.
    Takizawa Y; Sawada T; Suzuki A; Yamada R; Inoue T; Yamamoto K
    Scand J Rheumatol; 2005; 34(3):212-5. PubMed ID: 16134727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren syndrome.
    Nissinen R; Paimela L; Julkunen H; Tienari PJ; Leirisalo-Repo M; Palosuo T; Vaarala O
    Scand J Rheumatol; 2003; 32(6):337-42. PubMed ID: 15080264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
    Chang X; Yamada R; Suzuki A; Sawada T; Yoshino S; Tokuhiro S; Yamamoto K
    Rheumatology (Oxford); 2005 Jan; 44(1):40-50. PubMed ID: 15466895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis.
    Chang X; Yamada R; Sawada T; Suzuki A; Kochi Y; Yamamoto K
    Rheumatology (Oxford); 2005 Mar; 44(3):293-8. PubMed ID: 15561738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
    Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
    BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of serum peptidylarginine deiminase 4 in rheumatoid arthritis].
    Qian L; Shi HX; Li XP; Zhang H; Li XM; Wang GS
    Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):107-10. PubMed ID: 21418828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis: no influence of the presence of anti-citrullinated peptide antibodies.
    Faragó B; Talián GC; Maász A; Magyari L; Horvatovich K; Kovács B; Cserép V; Kisfali P; Kiss CG; Czirják L; Melegh B
    Clin Exp Rheumatol; 2007; 25(4):523-8. PubMed ID: 17888206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis.
    Suzuki A; Yamada R; Chang X; Tokuhiro S; Sawada T; Suzuki M; Nagasaki M; Nakayama-Hamada M; Kawaida R; Ono M; Ohtsuki M; Furukawa H; Yoshino S; Yukioka M; Tohma S; Matsubara T; Wakitani S; Teshima R; Nishioka Y; Sekine A; Iida A; Takahashi A; Tsunoda T; Nakamura Y; Yamamoto K
    Nat Genet; 2003 Aug; 34(4):395-402. PubMed ID: 12833157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peptidylarginine deiminase type4 (PADI4) role in immune system].
    Seri Y; Shoda H; Matsumoto I; Sumida T; Fujio K; Yamamoto K
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(3):154-9. PubMed ID: 24974927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of PADI4 in synovium of rheumatoid arthritis.
    Chang X; Zhao Y; Sun S; Zhang Y; Zhu Y
    Rheumatol Int; 2009 Oct; 29(12):1411-6. PubMed ID: 19199100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis.
    Darrah E; Rosen A; Giles JT; Andrade F
    Ann Rheum Dis; 2012 Jan; 71(1):92-8. PubMed ID: 21859690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid.
    Spengler J; Lugonja B; Ytterberg AJ; Zubarev RA; Creese AJ; Pearson MJ; Grant MM; Milward M; Lundberg K; Buckley CD; Filer A; Raza K; Cooper PR; Chapple IL; Scheel-Toellner D
    Arthritis Rheumatol; 2015 Dec; 67(12):3135-45. PubMed ID: 26245941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis.
    Darrah E; Kim A; Zhang X; Boronina T; Cole RN; Fava A; Giles JT; Bingham III CO; Chalmers MJ; Griffin PR; Sadegh-Nasseri S; Rosen A
    J Proteome Res; 2017 Jan; 16(1):355-365. PubMed ID: 27700100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases.
    Umeda N; Matsumoto I; Kawaguchi H; Kurashima Y; Kondo Y; Tsuboi H; Ogishima H; Suzuki T; Kagami Y; Sakyu T; Ishigami A; Maruyama N; Sumida T
    Clin Rheumatol; 2016 May; 35(5):1181-8. PubMed ID: 26415740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PADI4 Epigenetically Suppresses p21 Transcription and Inhibits Cell Apoptosis in Fibroblast-like Synoviocytes from Rheumatoid Arthritis Patients.
    Fan L; Zong M; Gong R; He D; Li N; Sun LS; Ye Q; Yu S
    Int J Biol Sci; 2017; 13(3):358-366. PubMed ID: 28367100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis.
    Too CL; Murad S; Dhaliwal JS; Larsson P; Jiang X; Ding B; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Res Ther; 2012 Nov; 14(6):R250. PubMed ID: 23164236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis.
    Harris ML; Darrah E; Lam GK; Bartlett SJ; Giles JT; Grant AV; Gao P; Scott WW; El-Gabalawy H; Casciola-Rosen L; Barnes KC; Bathon JM; Rosen A
    Arthritis Rheum; 2008 Jul; 58(7):1958-67. PubMed ID: 18576335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene.
    Yamada R; Suzuki A; Chang X; Yamamoto K
    Trends Mol Med; 2003 Nov; 9(11):503-8. PubMed ID: 14604829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis.
    Suzuki A; Yamada R; Ohtake-Yamanaka M; Okazaki Y; Sawada T; Yamamoto K
    Biochem Biophys Res Commun; 2005 Jul; 333(2):418-26. PubMed ID: 15950180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.